Presentation is loading. Please wait.

Presentation is loading. Please wait.

Study on surgical site infection

Similar presentations


Presentation on theme: "Study on surgical site infection"— Presentation transcript:

1 Study on surgical site infection
Ajita Mehta, Shireen Samson, Shweta Ghag, Sudeep Shah, Camilla Rodrigues, F. D. Dastur Infection Control Committee, P. D. Hinduja National Hospital & Medical Research Center, Mahim, Mumbai

2 INTRODUCTION contaminated cases Wound infection in clean & clean -
 % worldwide  Cause of morbidity, cost, hospital stay  Index of quality care  Surgeons may be wary of wound infections Irrational antibiotic policy: Prolonged duration, Peculiar combinations, Overkill, Leads to drug resistance (major problem)

3 Infection Rate – year 2003 Month Overall Infected Pulmonary urinary tract Clean Rate Vascular infection infection (%) cases (%) (%) (%) /1000days Jan Feb Mar Apr May Jun Jul Aug Oct Nov Dec

4 Objectives Current rate of Surgical Site infections
b) Assess role of rational antibiotic policy

5 Material & Methods Prospective & Consecutive cases
Clean & clean contaminated surgery cases (no contamination of the operative field by uncontrolled spillage of visceral contents) No breach in asepsis e.g. hernia, arthroplasty CABG, Cholecystectomy

6 Specialities included:
Exclusions :  Endoscopy  Laparoscopic surgery  Urological & Gynaec procedures Specialities included:  General & Oncosurgery,  Orthopedics,  Cardiac surgery

7 * Patient recruitment * Assessment  From theatre list DAILY
 Day 1/2 visit – proforma entry, contact no.  Day 8th visit Rounds- staff nurse information  Information from resident doctor Microbiology review Day 30th phone call to patients

8 RESULTS Duration of study: 7 months (Nov’03 to May’ 04)
Total number of cases studied: Speciality No.of cases Infected Percentage General Surgery % Ortho % CVTS % Total : %

9 Surgeon Total Infected Antibiotic
cases (Days) ORTH(469) A (1.5%) Cefazolin (3 doses) B Cefuroxime (3 doses) C (0.7%) Cefazolin (5 doses) D Cefazolin (3 doses) E Cefazolin (3doses)

10 Surgeon Total Infected Antibiotic Cases (Days) CVTS (228)
A (4.0%) Amox-clav/Amikacin/Tobramycin(5) B (2.8%) Cefuroxime/Amikacin (3-5) C (1.3%) Cefpirome (3) D (7.4%) Cefpirome (5-7) E Cefuroxime (2-3) F Cefepime (2-3)

11 Surgeon Total Infected Antibiotic Cases (Days)
General Surgery (303) Surgeon Total Infected Antibiotic Cases (Days) A Cefuroxime (3 dose) 5 days oral B Ceftriaxome (2 dose) C Cefuroxime (3 dose) D (3.1%) Cefazolin (3-5 dose) E Cefuroxime (3 dose) F Cefazolin (3 dose)

12 Surgeon Total Infected Antibiotic
Cases (Days) G Cefotaxime/ceftazidime H Cefazolin (3 dose) I Cefotaxime(3doses) J Augmentin (3 dose) K Cefuroxime (3 dose) L Amp/Amikacin (3 dose)

13 * Following hospital guidelines -- 5 /550
* Not following guidelines (Higher antibiotics) -- 7/450 * No significant difference in the above 2 but, - it increases the antibiotic resistance, - it increases cost to the patient due to higher antibiotic, - preserve higher antibiotics for serious cases

14 How is this study better than current available information?
• Accurate inclusion of all cases (denominator) from OT list • Accurate assessment of wound infection (numerator) by survey & phone call

15 CONCLUSION Infection rate is the same irrespective of antibiotics used
 The rate of infections is low in this study

16 RECOMMENDATIONS Rational hospital antibiotic policy should be followed by all: Single dose of cefuroxime / cefazolin in clean cases 3 doses in clean contaminated cases.

17 THANK YOU !


Download ppt "Study on surgical site infection"

Similar presentations


Ads by Google